Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ĵµð´Ù´¢Áõ ȯÀÚ¿¡¼­ Fluconazole °æ±¸Åõ¿©¿Í Amphotericin B Áö¼ÓÀû ¹æ±¤¼¼Ã´ÀÇ Ä¡·á È¿°ú ºñ±³ Continuous Bladder Irrigation with Amphotericin B versus Oral Administration of Fluconazole in Patients with Candiduria

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 9È£ p.870 ~ 874
±èÇü³², ÀÌÁö¿µ, ³ªÈñ»ï,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇü³² (  ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

ÀÌÁö¿µ (  ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
³ªÈñ»ï (  ) 
Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

¼­·Ð
ĵµð´Ù´¢ÁõÀº Á¤»óÀΰ£ÀÇ ÀεÎ, °áÀå ¹× Áú ³»¿¡ »óÁ¸ÇÏ´Â Áø±ÕÀ̳ª, ¹«±Õ»óÅ¿¡¼­ ¹è´¢µÈ
¿ä°Ëü¿¡¼­´Â µ¿Á¤µÇÁö ¾Ê¾Æ¾ß ÇÏ°í, ¸¸ÀÏ ¿ä¹è¾ç°Ë»ç¿¡¼­ ĵµð´Ù°¡ µ¿Á¤µÉ °æ¿ì ¹æ±¤³» °¨
¿°À» ¸ÕÀú »ý°¢ÇÒ ¼ö ÀÖ´Ù. ´Ù¸¥ Àü½Å¼º Áø±Õ°¨¿°°ú ¸¶Âù°¡Áö·Î ĵµð´Ù´¢Áõµµ ¾à¹° ¶Ç´Â Áú
º´(Á¾¾ç, ´ç´¢ µî)¿¡ ÀÇÇÑ Á¤»óÀû ¹æ¾î±âÀüÀÇ º¯È­¿Í ¿¬°üµÇ¾î ÀÖ´Ù. ĵµð´Ù´¢ÁõÀ» ÀûÀýÈ÷
Ä¡·áÇÏÁö ¾ÊÀ» °æ¿ì »óÇ༺ °¨¿°À¸·Î ÀÎÇÏ¿© Áø±Õ±¸ Çü¼º, Àü½Å°¨¿° ¶Ç´Â ½ÅÀåĵµð´ÙÁõ µî
ÀÇ ÇÕº´ÁõÀ¸·Î ¹ßÀüÇÒ ¼ö ÀÖÀ¸¹Ç·Î ÀûÀýÇÑ Ä¡·á°¡ ÇÊ¿äÇÏ´Ù. ÀÔ¿øȯÀÚÀÇ ¿ä¹è¾ç°Ë»ç½Ã Àüü
ÀÇ ¾à 1-8%¿¡¼­ È¿¸ð³ª ĵµð´Ù°¡ µ¿Á¤µÈ´Ù°í ÇÏ°í ±×Áß Candlda albicans°¡ 50% ÀÌ»óÀ»
Â÷Áö Çϸç, ºñ´¢»ý½Ä±â ĵµð´Ù°¨¿°Àº ±¤¹üÀ§ Ç×»ýÁ¦ÀÇ »ç¿ë, Àå±â°£ Ä«Å×ÅÍÀ¯Ä¡, ¸é¿ª¾ïÁ¦Á¦
»ç¿ëÁõ°¡, ¹æ»ç¼± Ä¡·á µîÀ¸·Î Á¡Á¡ Áõ°¡ÇÏ´Â Ãß¼¼ÀÌ´Ù.
ĵµð´Ù´¢ÁõÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â Ç×Áø±ÕÁ¦·Î´Â amph-otericin B, flucytocine, imidazole µî
ÀÌ ÀÖ´Ù. amphotericin B´Â Áø±ÕÀÇ ¿øÇüÁú¸·¿¡ ÀÖ´Â sterol¿¡ °áÇÕÇÏ¿© Áø±ÕÀÇ ¼¼Æ÷º®ÀÇ Åõ
°ú¼ºÀ» Áõ°¡½ÃÄÑ ¿ëÇؽÃÅ´À¸·Î¼­ Ç×Áø±ÕÀÛ¿ëÀ» ³ªÅ¸³»¸ç ÃÖ±Ù±îÁö ĵµð´Ù´¢ÁõÀÇ Ä¡·á·Î¼­
¹æ±¤¼¼Ã´¿¡ ¸¹ÀÌ »ç¿ëµÇ¾î ¿ÔÀ¸³ª, ½Åµ¶¼º µî ½ÉÇÑ ºÎÀÛ¿ë ¶§¹®¿¡ Àü½ÅÅõ¿©´Â Àü½Åĵµð´ÙÁõ
¿Ü¿¡´Â »ç¿ëÀÌ Á¦ÇÑµÇ¾î ¿Ô´Ù. aucytoculeÀº À§ÀåÀå¾Ö, °£±â´É ÀúÇÏ, °ñ¼ö¾ïÁ¦ µîÀÇ ºÎÀÛ¿ë
°ú °í³óµµ·Î ¼Òº¯À¸·Î ¹èÃâµÇ±â ¶§¹®¿¡ ½ÅÀå±â´É ÀúÇÏ ½Ã´Â ¿ë·®À» °¨¼ÒÇÏ¿© »ç¿ëÇØ¾ß ÇÏ´Â
´ÜÁ¡ÀÌ ÀÖ´Ù. imidazoleÀº ÀÏÂ÷ÀûÀ¸·Î °£¿¡¼­ ´ë»çµÇ°í ¾ÆÁÖ ÀûÀº ¾ç¸¸ÀÌ ¿ä·Î ¹è¼³µÇ¹Ç·Î
ĵµð´Ù´¢ÁõÀÇ Ä¡·á¿¡ »ó´çÈ÷ Á¦ÇÑÀûÀ¸·Î »ç¿ëµÇ¾î ¿Ô´Ù
ÀÌ·± Á¦ÇÑÁ¡À» ±Øº¹Çϱâ À§ÇØ ÃÖ±Ù °³¹ßµÈ fluconazoleÀº ergosterolÇÕ¼ºÀ» Â÷´ÜÇÏ¿© Áø±Õ
º®ÀÇ Åõ°ú¼ºÀ» º¯È­½ÃÄÑ Ç×Áø±ÕÈ¿°ú¸¦ ³ªÅ¸³½´Ù ƯÈ÷ Àå³»¿¡¼­ Àß Èí¼öµÇ°í º¯È­µÇÁö ¾ÊÀº
ä 70%°¡ ¿ä·Î ¹è¼³µÇ¹Ç·Î ĵµð´Ù´¢ÁõÀÇ Ä¡·á¿¡ ÁÁÀº ¾à¹°·Î ¾Ë·ÁÁ® ÀÖ°í, Candlda
albiscans¿Í non-albilcansÁ¾¿¡ ÀÇÇÑ ¿ä·Î°¨¿° ȯÀÚ¿¡¼­ ³ôÀº Ä¡·á¼ºÀûÀÌ º¸°íµÇ°í ÀÖ´Ù.
ÀÌ¿¡ º» ÀúÀÚµéÀº Ä«Å×Å͸¦ Á¦°ÅÇÒ ¼ö ¾ø°í ±Ý½ÄÀÌ ÇÊ¿äÇϰųª °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚ¿¡¼­ÀÇ
amphotericin B Áö¼ÓÀû ¹æ±¤¼¼Ã´°ú Ä«Å×ÅÍÀ¯Ä¡°¡ ÇÊ¿ä¾ø°Å³ª Ä«Å×ÅÍÀ¯Ä¡ÁßÀÌ¶óµµ °Åµ¿ÀÌ
ÀÚÀ¯·Ó°í ±Ý½ÄÀÌ ÇÊ¿ä ¾ø´Â ȯÀÚ¿¡¼­ÀÇ fluconazole°æ±¸Åõ¿©ÀÇ È¿°ú¸¦ ºñ±³ÇÏ¿© ȯÀÚÀÇ »óÅÂ
¿¡ µû¸¥ Ä¡·á¹æħÀÇ °áÁ¤¿¡ ´ëÇÏ¿© µµ¿òÀ» ÁÖ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇà ÇÏ¿´´Ù
#ÃÊ·Ï#
Purpose: The efficacy of continuous bladder irrigation with amphotericin B versus oral
administration of fluconazole(Diflucan ) was compared in the treatment of
patients with candiduria.
. Materials and Methods: A prospective and comparative study of candiduriawas done
on 28 patients(Amphotericin B: 13, Fluconazole: 15). Continuous bladder irrigation with
50§· amphotericin B/¥é sterile water infused during 24 hours for 2 days was compared
to oral administration of 50-100§·/day fluconazole for a range of 7-14 days. Urine
culture were obtained 3days, 7 days after continuous bladder irrigation with amphotericin
B and 7 days, 14 days after oral administration of fluconazole.
Results: The organism was eradicated in 10 patients(76.9%) who received continuous
irrigation of amphotericin B and 11 patients(73.3%) who received oral fluconazole
therapy. So, There was no statistically significant difference between continuous bladder
irrigation with Amphotericin B group and oral medication of fluconazole group(p>0.05).
Conclusions: There was no difference in the cure rate of candiduria between
continuous bladder irrigation with Amphotericin B group and oral medication of
fluconazole group. So, patient's condition(Foley catheterization, possibility of ambulation
and oral feeding) and convinience will be the important deciding factors to select
adequate treatment method of candiduria.

Å°¿öµå

Candiduria; Amphotericin B; Fluconazole;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS